Most Read from Bloomberg Musk Revives $44 Billion Twitter Bid, Aiming to Avoid Trial Loretta Lynn, Coal Miner's Daughter And Country Queen, Dies Elon Musk Sets Off Uproar in Ukraine by Tweeting His ‘Peace’ Plan Biden, Kishida Condemn North Korean Missile Launch Over Japan Stock Shorts Fold in Best Two-Day Rally Since 2020: Markets Wrap The US data-analytics company aimed to buy up smaller rivals that already had an existing relationship with the NHS, according to emails and strategy documents seen by Bloomberg.While Palantir has so far been unsuccessful in buying up NHS suppliers, the documents seen by Bloomberg show how Palantir hopes to deepen its business with a key client, both by making key hires from the NHS and via potential acquisitions.Palantir has consistently faced criticism in countries including the US and UK from civil liberties groups, who have been concerned by its track record for providing tools to government agencies that help enable broad surveillance of populations, for example by US Customs and Enforcement to find undocumented migrants for deportation.Its website states that the company “was founded on the conviction that it’s essential to preserve fundamental principles of privacy and civil liberties while using data.” NHS England spokesman James Kell said the upcoming contract would be awarded through an “open and transparent process” with strict requirements including “ensuring data remains secure and within the NHS.” Eighty-six suppliers attended pre-market engagement events, he said.‘Start Scoping’ Co-founded in 2003 by Facebook Inc. board member Peter Thiel, Palantir quickly won the attention and financial backing of In-Q-Tel, the venture investing arm of the U.S. Central Intelligence Agency."